<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03331588</url>
  </required_header>
  <id_info>
    <org_study_id>leijiang</org_study_id>
    <nct_id>NCT03331588</nct_id>
  </id_info>
  <brief_title>Comparison of Post-operative Pain and Quality of Life Between Subxiphoid and Intercostal VATS for Lung Cancer</brief_title>
  <official_title>Comparison Study of Post-operative Pain and Quality of Life Between Subxiphoid and Intercostal Vedio-assisted Thoracic Surgery for Radical Lung Cancer Resection</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shanghai Pulmonary Hospital, Shanghai, China</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shanghai Pulmonary Hospital, Shanghai, China</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      One-thirds of patients underwent video-assisted thorascopic surgery (VATS) still have severe&#xD;
      pain.Uniportal lobectomy or segmentectomies emerged as a promising and exciting approach for&#xD;
      minimally invasive thoracic surgery. However, nearly all reported uniportal VATS lobectomies&#xD;
      have been performed via the intercostal route, and chest wall trauma has still occurred.&#xD;
      Here,the investigators undertook novel uniportal VATS technique involving a subxiphoid route&#xD;
      for pulmonary lobectomies or segmentectomies.We would like to evaluate the post-operative&#xD;
      pain and quality of life between Subxiphoid and Intercostal VATS for Lung Cancer.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Is subxiphoid route VATS surgery better than Intercostal VATS surgery for lung cancer?&#xD;
&#xD;
      Video assisted thoracoscopic surgery for lung cancer (VATS) is less traumatic than&#xD;
      traditional open surgery for lung cancer. A novel uniportal VATS technique involving a&#xD;
      subxiphoid route for thoracic surgery has been occured. It is reported that subxiphoid route&#xD;
      VATS surgery is better than Intercostal VATS surgery in post-operative pain and quality of&#xD;
      life, but this has never been documented in a randomized trial. Some surgeons hesitate to use&#xD;
      subxiphoid VATS because it is technically more demanding, others question if the two methods&#xD;
      are oncologically equal. Regardless, VATS has been implemented as a routine method for lung&#xD;
      cancer surgery several places around the world, while Shanghai pulmonary Hospital is one of&#xD;
      the best to perform subxiphoid VATS. The investigators have launched the first randomized&#xD;
      controlled trial in the world comparing the two surgical methods to investigate any&#xD;
      differences in length of hospitalization, postoperative pain, life quality within the first&#xD;
      year.&#xD;
&#xD;
      The investigators include patients with stage I lung cancer, and randomize between subxiphoid&#xD;
      VATS and Intercostal VATS in a design where both the patient and doctors doing general rounds&#xD;
      in the ward are blinded until discharge because the dressing on the surgical wound is&#xD;
      identical, regardless of the surgical method. The surgeon cannot influence clinical decisions&#xD;
      including time to discharge, which is decided by other specialist surgeons. Pain evaluation&#xD;
      is performed 1 time daily and followed 6 months using the VAS-score, life quality is&#xD;
      evaluated continuously during the first 6 months using SF-MPQ-2 questionnaires.&#xD;
&#xD;
      200 patients will be asked to participate in each study at shanghai pulmonary Hospital,china&#xD;
      in collaboration with surgeons from department of thoracic surgery.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 10, 2017</start_date>
  <completion_date type="Actual">February 28, 2020</completion_date>
  <primary_completion_date type="Actual">February 28, 2020</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Parallel Assignment</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
    <masking_description>In the operating room a dressing will be placed so that it covers the entire hemithorax whereby the incision is hidden. This is done identically regardless of surgical technique. This dressing is left in place until discharge. If changing of the dressing is needed, either the project-nurse or a nurse for another team will assist.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative pain</measure>
    <time_frame>6 months</time_frame>
    <description>visual analogue score (VAS-score) is to asses the development of acute and chronic pain after VATS surgery. 11 point numeric rating scale of 0 represented &quot;no pain&quot;and a score of 10 represented &quot;worst pain &quot;.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>6 months</time_frame>
    <description>SF-MPQ-2 questionnaire is used.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">200</enrollment>
  <condition>Lung Neoplasms</condition>
  <condition>Thoracic Surgery</condition>
  <condition>Carcinoma, Non-Small-Cell Lung</condition>
  <condition>Lung Diseases</condition>
  <condition>Carcinoma, Bronchogenic</condition>
  <condition>Thoracic Neoplasm</condition>
  <arm_group>
    <arm_group_label>Subxiphoid uniportal VATS</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard Subxiphoid single-port video assisted thoracic surgery, no use of rib-spreader.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intercostal uniportal VATS</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard Intercostal single-port video assisted thoracic surgery, no use of rib-spreader.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Subxiphoid uniportal VATS</intervention_name>
    <description>Patients were placed in a supine position, and the operating table was manipulated as needed to elevate the appropriate side of the body for surgery. The surgical procedures followed principles of pulmonary resections</description>
    <arm_group_label>Subxiphoid uniportal VATS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Intercostal uniportal VATS</intervention_name>
    <description>The surgical procedures followed principles of pulmonary resections</description>
    <arm_group_label>Intercostal uniportal VATS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Eligible for surgery for lunge cancer.&#xD;
&#xD;
        Elective surgery (surgery planed &gt; 2 days).&#xD;
&#xD;
        Accepts randomization.&#xD;
&#xD;
        Age 18 or above.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Previous thoracic surgery.&#xD;
&#xD;
        Any type of chronic pain, requiring daily use of analgetics.&#xD;
&#xD;
        pregnant.&#xD;
&#xD;
        Breast feeding.&#xD;
&#xD;
        contraindications to NSAID.&#xD;
&#xD;
        Chemo- and/or radiotherapy in connection to present admission.&#xD;
&#xD;
        Major surgery planned in connection to this admission.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Shanghai Pulmonary Hospital</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200433</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Gonzalez-Rivas D, Yang Y, Lei J, Hernandez L, Jiang G. Subxiphoid uniportal video-assisted thoracoscopic middle lobectomy and anterior anatomic segmentectomy (S3). J Thorac Dis. 2016 Mar;8(3):540-3. doi: 10.21037/jtd.2016.02.63.</citation>
    <PMID>27076952</PMID>
  </reference>
  <reference>
    <citation>Hernandez-Arenas LA, Lin L, Yang Y, Liu M, Guido W, Gonzalez-Rivas D, Jiang G, Jiang L. Initial experience in uniportal subxiphoid video-assisted thoracoscopic surgery for major lung resections. Eur J Cardiothorac Surg. 2016 Dec;50(6):1060-1066. doi: 10.1093/ejcts/ezw189. Epub 2016 Jul 11.</citation>
    <PMID>27401700</PMID>
  </reference>
  <reference>
    <citation>Song N, Zhao DP, Jiang L, Bao Y, Jiang GN, Zhu YM, Ding JA. Subxiphoid uniportal video-assisted thoracoscopic surgery (VATS) for lobectomy: a report of 105 cases. J Thorac Dis. 2016 Mar;8(Suppl 3):S251-7. doi: 10.3978/j.issn.2072-1439.2016.02.32.</citation>
    <PMID>27014471</PMID>
  </reference>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>November 1, 2017</study_first_submitted>
  <study_first_submitted_qc>November 3, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 6, 2017</study_first_posted>
  <last_update_submitted>February 28, 2020</last_update_submitted>
  <last_update_submitted_qc>February 28, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 2, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Shanghai Pulmonary Hospital, Shanghai, China</investigator_affiliation>
    <investigator_full_name>Lei Jiang</investigator_full_name>
    <investigator_title>associate chief physician</investigator_title>
  </responsible_party>
  <keyword>Lung cancer</keyword>
  <keyword>Pain</keyword>
  <keyword>Quality of life</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carcinoma</mesh_term>
    <mesh_term>Lung Neoplasms</mesh_term>
    <mesh_term>Neoplasms</mesh_term>
    <mesh_term>Carcinoma, Non-Small-Cell Lung</mesh_term>
    <mesh_term>Thoracic Neoplasms</mesh_term>
    <mesh_term>Carcinoma, Bronchogenic</mesh_term>
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

